
Lupin Limited has informed the Exchange regarding a press release dated Jun 17, 2021, titled "Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets".
Filed with NSE ·

Lupin Limited has informed the Exchange regarding a press release dated Jun 17, 2021, titled "Lupin Receives U.S. FDA Approval for Sevelamer Hydrochloride Tablets".
6ix hasn’t read this filing yet.
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin